C D Evans

530 total citations
15 papers, 437 citations indexed

About

C D Evans is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, C D Evans has authored 15 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Surgery. Recurrent topics in C D Evans's work include Cardiovascular Effects of Exercise (4 papers), Mitochondrial Function and Pathology (2 papers) and Alzheimer's disease research and treatments (2 papers). C D Evans is often cited by papers focused on Cardiovascular Effects of Exercise (4 papers), Mitochondrial Function and Pathology (2 papers) and Alzheimer's disease research and treatments (2 papers). C D Evans collaborates with scholars based in United States, Sweden and China. C D Evans's co-authors include Murray Oratz, William Duane, Eugene G. DeMaster, Bradford G. Stone, Sidney S. Schreiber, Marcus A. Rothschild, Rothschild Ma, SS Schreiber, William F. Prigge and W C Duane and has published in prestigious journals such as Journal of Clinical Investigation, Circulation Research and Biochemical Journal.

In The Last Decade

C D Evans

14 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C D Evans United States 10 154 118 92 80 58 15 437
Jürgen C. Frölich Germany 10 115 0.7× 22 0.2× 127 1.4× 42 0.5× 20 0.3× 13 509
G. Howard Smith United Kingdom 6 213 1.4× 44 0.4× 20 0.2× 52 0.7× 98 1.7× 8 504
Dipak K. Das United States 9 131 0.9× 28 0.2× 28 0.3× 24 0.3× 14 0.2× 10 404
Lingling Jiang China 15 221 1.4× 21 0.2× 50 0.5× 51 0.6× 16 0.3× 27 494
C Largillière France 13 341 2.2× 21 0.2× 21 0.2× 47 0.6× 45 0.8× 30 608
Veronika Fekete Hungary 13 115 0.7× 108 0.9× 95 1.0× 46 0.6× 12 0.2× 21 504
Tadanobu Takamura Japan 10 146 0.9× 20 0.2× 24 0.3× 12 0.1× 23 0.4× 24 366
Päivi Pöhö Finland 11 285 1.9× 48 0.4× 35 0.4× 41 0.5× 17 0.3× 15 442
Vincenzo Lembo Italy 11 124 0.8× 90 0.8× 12 0.1× 20 0.3× 15 0.3× 17 404
Katharina M. Rund Germany 15 207 1.3× 25 0.2× 26 0.3× 46 0.6× 18 0.3× 23 619

Countries citing papers authored by C D Evans

Since Specialization
Citations

This map shows the geographic impact of C D Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C D Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C D Evans more than expected).

Fields of papers citing papers by C D Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C D Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C D Evans. The network helps show where C D Evans may publish in the future.

Co-authorship network of co-authors of C D Evans

This figure shows the co-authorship network connecting the top 25 collaborators of C D Evans. A scholar is included among the top collaborators of C D Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C D Evans. C D Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gueorguieva, Ivelina, Kay Hoong Chow, Laiyi Chua, et al.. (2025). Donanemab exposure‐response in early symptomatic Alzheimer's disease. Alzheimer s & Dementia. 21(7). e70491–e70491. 5 indexed citations
2.
Mintun, Mark A., Craig Ritchie, Paul R. Solomon, et al.. (2024). 1978 Donanemab in early symptomatic Alzheimer’s Disease: Efficacy and safety in TRAILBLAZER-ALZ 2, Phase 3 Randomized Clinical Trial. Age and Ageing. 53(Supplement_1). 2 indexed citations
3.
Navrátil, Tomáš, C D Evans, Amy Schaberg, et al.. (2010). Aerosol and pharmacokinetic properties of denufosol support its use for early intervention in CF lung disease. Journal of Cystic Fibrosis. 9. S21–S21. 1 indexed citations
4.
Stone, Bradford G., et al.. (1993). Effect of regulating cholesterol biosynthesis on breath isoprene excretion in men. Lipids. 28(8). 705–708. 136 indexed citations
5.
Evans, C D, et al.. (1992). Evidence for a common biliary cholesterol and VLDL cholesterol precursor pool in rat liver.. Journal of Lipid Research. 33(11). 1665–1675. 17 indexed citations
6.
Evans, C D, et al.. (1992). Thyroid hormone differentially augments biliary sterol secretion in the rat. I. The isolated-perfused liver model.. Journal of Lipid Research. 33(10). 1459–1466. 13 indexed citations
7.
Evans, C D, et al.. (1989). Regulation of hepatic cholesterol ester hydrolase and acyl-coenzyme A:cholesterol acyltransferase in the rat.. Journal of Lipid Research. 30(11). 1681–1690. 30 indexed citations
8.
Evans, C D, et al.. (1989). Lovastatin treatment inhibits sterol synthesis and induces HMG-CoA reductase activity in mononuclear leukocytes of normal subjects.. Journal of Lipid Research. 30(12). 1943–1952. 49 indexed citations
9.
Schreiber, Shaul, et al.. (1986). The basal level of cardiac protein synthesis. Journal of Molecular and Cellular Cardiology. 18. 10–10. 1 indexed citations
10.
Evans, C D, Sidney S. Schreiber, Murray Oratz, & Marcus A. Rothschild. (1981). Relative synthesis of cardiac contractile proteins. Evidence for synthesis from the same precursor pool. Biochemical Journal. 194(3). 673–678. 13 indexed citations
11.
Schreiber, Sidney S., C D Evans, Murray Oratz, & Marcus A. Rothschild. (1981). Protein synthesis and degradation in cardiac stress.. Circulation Research. 48(5). 601–611. 52 indexed citations
12.
Schreiber, Sidney S., et al.. (1975). The effect of pressure or flow stress on right ventricular protein synthesis in the face of constant and restricted coronary perfusion.. Journal of Clinical Investigation. 55(1). 1–11. 31 indexed citations
13.
Schreiber, SS, et al.. (1973). Cardiac protein degradation in acute overload in vitro: reutilization of amino acids. American Journal of Physiology-Legacy Content. 224(2). 338–345. 48 indexed citations
14.
Schreiber, SS, Murray Oratz, C D Evans, Eric S. Silver, & Rothschild Ma. (1968). Effect of acute overload on cardiac muscle mRNA. American Journal of Physiology-Legacy Content. 215(5). 1250–1259. 39 indexed citations
15.
Evans, C D & Peter Stradling. (1953). Effect of Isoniazid on Carbohydrate Metabolism. BMJ. 1(4812). 729–730.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026